Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Genes and apps could limit health check invites
Fri August 16th - The NHS could seek to cut the cost of screening middle-aged adults by using apps and AI, it was announced today. More
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
guide to breast disorders guide to womb disorders guide to menopause Complete Women's Health: from The Royal College of Obstetricians and Gynaecologists For books and family gift ideas click here
RSS graphic XML Graphic

Global challenges for women with ovarian cancer

Friday October 19th, 2018

Most women with ovarian cancer had never heard of the disease before they were diagnosed, a global study has revealed.

The World Ovarian Cancer Coalition Every Woman Study, the largest review detailing experiences of women with ovarian cancer, has found that there are low levels of awareness of the disease, which results in delays for seeking medical help.

The survey, which questioned more than 1,500 women in 44 countries, also showed that a lack of awareness among doctors could also be a significant factor with regards to a delay in diagnosis. Variations in access to genetic testing and specialist treatment have also been highlighted.

The study, which was launched ahead of the European Society for Medical Oncology (ESMO) 2018 Congress, Munich, Germany, found that nine out of ten of women experienced symptoms prior to diagnosis and that of those, eight in ten consulted a doctor. However, less than half visited their GP within a month and one in ten waited six months.

Globally, diagnosis took an estimated average of 31 weeks from a woman experiencing symptoms. However, diagnosis was confirmed more than a year after visiting a doctor for one in ten women.

The study said while there are examples of best practice in prevention, diagnosis and treatment of ovarian cancer across the world, but there is no one country that excels in all three areas.

Germany has the fastest diagnosis, although half of women are unlikely to receive specialist care, while the UK has fewest women diagnosed within a month of visiting a doctor and almost universal access to specialist clinicians.

Researchers found that awareness of the disease is high in Canada and although women seek medical support, diagnosis is slow. In Japan, awareness is very low and fewer women consult their doctors, but they diagnosed faster than in other countries surveyed.

Elisabeth Baugh, chair of the Coalition and CEO of Ovarian Cancer Canada, said: “We wanted to find out more about the experiences of women with ovarian cancer and identify what needs to be done right now to tackle this marginalised cancer. The results show that this is a global challenge that can only be taken on by the whole community.”

Annwen Jones, CEO of Target Ovarian Cancer in the UK and co-chair of the study, added: “This study, for the first time, provides powerful evidence of the challenges faced by women diagnosed with ovarian cancer across the world, and sets an agenda for global change.

“We were especially shocked by the widespread, woeful lack of awareness of ovarian cancer. It is vital that urgent steps are taken in every country to raise awareness of the disease and speed up diagnosis so that we can transform the outlook for the increasing numbers of women and their families affected by ovarian cancer around the world.”

Tags: Cancer | Europe | Women's Health & Gynaecology | World Health

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)